Search results
Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for...
FOX 59 Indianapolis· 2 hours agoBioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai announced today that they have...
Bioworld announces expansion of Minecraft collaboration
VentureBeat· 13 hours agoBioworld, the brand merchandising company, announced today it’s continuing and expanding its ...
... Enters Five-Year, Multimillion Dollar Research Collaboration with MIT AgeLab to Drive Longevity...
WTNH-TV New Haven· 14 hours agoJohn Hancock, along with its Toronto-based parent company Manulife (NYSE: MFC), today announced a...
Bayer sees rise of more innovative drugs
China Daily· 2 hours agoWith China offering a constantly improving business environment, deeper industrial collaboration and more innovation, multinational corporations in the pharmaceutical industry ...
...Hateration, Holleration: Mary J. Blige Releases Limited Boot Collaboration With Giuseppe Zanotti,...
Bossip· 11 hours agoThe Queen of Hip-Hop Soul has finally released her own line of boots, but not everyone was able to...
LearnLM is Google's new family of AI models for education
TechCrunch via Yahoo Finance· 6 hours agoGoogle says it has developed a new family of generative AI models "fine-tuned" for learning:...
Caitlin Clark wears $1,500 Tiffany & Co x Nike sneakers to WNBA debut
New York Post· 3 hours agoThey also come with signature Tiffany & Co. sterling silver co-branded accessories like a shoe horn,...
Dead By Daylight X Castlevania collaboration announced
VideoGamer.com· 11 hours agoAlthough the Dead By Daylight Year 8 Anniversary Livestream was focused on the upcoming Dungeons and Dragons chapter, a teaser towards the end of the presentation got me more excited to jump ...
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to...
The Missourian· 2 days ago- Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to...
Valley City Times Record· 2 days ago- Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
